المؤلفون: Franks SE; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Santiago-Sanchez GS; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Fabian KP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Solocinski K; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Chariou PL; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Hamilton DH; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Kowalczyk JT; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Padget MR; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Gameiro SR; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Schlom J; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA., Hodge JW; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm 8B13, 10 Center Drive, Bethesda, MD, 20892, USA. jh241d@nih.gov.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Aug; Vol. 72 (8), pp. 2783-2797. Date of Electronic Publication: 2023 May 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen* , Neoplasms*, Mice ; Animals ; Docetaxel ; CD8-Positive T-Lymphocytes ; Interleukin-12/pharmacology ; Necrosis ; Tumor Microenvironment ; Cell Line, Tumor ; Immunotherapy

المؤلفون: Hoke ATK; Sinonasal and Skull Base Tumor Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health; Bethesda, MD, USA.; University of North Carolina at Chapel Hill, School of Medicine; Chapel Hill, NC, USA., Padget MR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Bethesda, MD, USA., Fabian KP; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Bethesda, MD, USA., Nandal A; Sinonasal and Skull Base Tumor Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health; Bethesda, MD, USA., Gallia GL; Department of Neurosurgery, Johns Hopkins University School of Medicine; Baltimore, MD, USA.; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine; Baltimore, MD, USA., Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National institutes of Health; Bethesda, MD, USA., Soon-Shiong P; ImmunityBio, Culver City, CA, USA., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Bethesda, MD, USA., London NR Jr; Sinonasal and Skull Base Tumor Program, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health; Bethesda, MD, USA.; Department of Neurosurgery, Johns Hopkins University School of Medicine; Baltimore, MD, USA.; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine; Baltimore, MD, USA.

المصدر: Cancer research communications [Cancer Res Commun] 2021 Dec; Vol. 1 (3), pp. 127-139.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun

مواضيع طبية MeSH: B7-H1 Antigen* , Chordoma*/therapy, Humans ; Cetuximab ; Cell Line, Tumor ; Neoplasm Recurrence, Local/pathology ; Killer Cells, Natural ; Immunotherapy ; Antibodies ; Neoplastic Stem Cells

المؤلفون: Lampert EJ; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Zimmer A; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Padget M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Cimino-Mathews A; Department of Pathology, The Johns Hopkins Medical Institution, Baltimore, Maryland., Nair JR; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Liu Y; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Swisher EM; Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, University of Washington, Seattle, Washington., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Nixon AB; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Nichols E; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland., Bagheri MH; Department of Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, Bethesda, Maryland., Levy E; Interventional Radiology, NIH Clinical Center, Bethesda, Maryland., Radke MR; Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, University of Washington, Seattle, Washington., Lipkowitz S; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Taube JM; Department of Dermatopathology, The Johns Hopkins Medical Institution, Baltimore, Maryland., Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Lee JM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. leej6@mail.nih.gov.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 15; Vol. 26 (16), pp. 4268-4279. Date of Electronic Publication: 2020 May 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , B7-H1 Antigen/*genetics , Ovarian Neoplasms/*drug therapy , Phthalazines/*administration & dosage , Piperazines/*administration & dosage , Poly(ADP-ribose) Polymerases/*genetics, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Chemokine CXCL10/genetics ; Chemokine CXCL9/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/adverse effects ; Interferon-gamma/genetics ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Phthalazines/adverse effects ; Piperazines/adverse effects ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Progression-Free Survival ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Robbins Y; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States., Greene S; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States., Friedman J; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States., Clavijo PE; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States., Van Waes C; Tumor Biology Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States., Fabian KP; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States., Padget MR; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States., Abdul Sater H; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, United States., Lee JH; NantKWest, Culver City, United States., Soon-Shiong P; NantKWest, Culver City, United States., Gulley J; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, United States., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States., Hodge JW; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States., Allen CT; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, United States.

المصدر: ELife [Elife] 2020 Jul 07; Vol. 9. Date of Electronic Publication: 2020 Jul 07.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen/*metabolism , Killer Cells, Natural/*physiology , Squamous Cell Carcinoma of Head and Neck/*metabolism, Animals ; Cell Line ; Cell Line, Tumor ; Humans ; Mice ; Mice, Inbred C57BL ; Mice, Inbred NOD ; Receptors, Chimeric Antigen/metabolism

المؤلفون: Fabian KP; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Padget MR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Solocinski K; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Robbins Y; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Allen CT; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, USA., Lee JH; ImmunityBio, Santa Cruz, California, USA., Rabizadeh S; NantOmics, Culver City, California, USA.; ImmunityBio, Culver City, California, USA., Soon-Shiong P; NantOmics, Culver City, California, USA.; ImmunityBio, Culver City, California, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA jh241d@nih.gov.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 May; Vol. 8 (1).

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen/*antagonists & inhibitors , Immunotherapy, Adoptive/*methods , Killer Cells, Natural/*transplantation , Myeloid-Derived Suppressor Cells/*immunology , Neoplasms/*therapy, Animals ; B7-H1 Antigen/immunology ; Cell Line, Tumor ; Combined Modality Therapy/methods ; Female ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/immunology ; GPI-Linked Proteins/metabolism ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Interleukin-2/genetics ; Interleukin-2/immunology ; Interleukin-2/metabolism ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Mice ; Myeloid-Derived Suppressor Cells/drug effects ; Neoplasms/immunology ; Neoplasms/pathology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/immunology ; Protein Engineering ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/metabolism ; Receptors, IgG/genetics ; Receptors, IgG/immunology ; Receptors, IgG/metabolism ; Tumor Escape/drug effects ; Tumor Escape/immunology ; Xenograft Model Antitumor Assays

المؤلفون: Nagaya T; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Nakamura Y; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Sato K; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Harada T; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Choyke PL; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America., Kobayashi H; Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States of America.

المصدر: Oncotarget [Oncotarget] 2017 Jan 31; Vol. 8 (5), pp. 8807-8817.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Infrared Rays*, Adenocarcinoma/*therapy , Adenocarcinoma, Papillary/*therapy , Antibodies, Monoclonal/*pharmacology , Antineoplastic Agents, Immunological/*pharmacology , B7-H1 Antigen/*antagonists & inhibitors , Immunotherapy/*methods , Lung Neoplasms/*therapy , Phototherapy/*methods, Adenocarcinoma/immunology ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adenocarcinoma of Lung ; Adenocarcinoma, Papillary/immunology ; Adenocarcinoma, Papillary/metabolism ; Adenocarcinoma, Papillary/pathology ; Animals ; Antibodies, Monoclonal, Humanized ; B7-H1 Antigen/immunology ; B7-H1 Antigen/metabolism ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Female ; Fluorescent Dyes/pharmacology ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Mice, Nude ; Time Factors ; Tumor Burden ; Xenograft Model Antitumor Assays

المؤلفون: Moore EC; Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Cash HA; Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Caruso AM; Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Uppaluri R; Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Van Waes C; Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland., Allen CT; Tumor Biology Section, Head and Neck Surgery Branch, National Institutes of Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland. clint.allen@nih.gov.

المصدر: Cancer immunology research [Cancer Immunol Res] 2016 Jul; Vol. 4 (7), pp. 611-20. Date of Electronic Publication: 2016 Apr 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*pharmacology , B7-H1 Antigen/*antagonists & inhibitors , Mouth Neoplasms/*immunology , Mouth Neoplasms/*metabolism , Protein Kinase Inhibitors/*pharmacology , TOR Serine-Threonine Kinases/*antagonists & inhibitors, Animals ; Antigens, Neoplasm/immunology ; Cell Line, Tumor ; Cytotoxicity, Immunologic ; Disease Models, Animal ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Lymphocyte Depletion ; Mice ; Molecular Targeted Therapy ; Mouth Neoplasms/drug therapy ; Mouth Neoplasms/pathology ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism

المؤلفون: Jochems, Caroline, Hodge, James W., Fantini, Massimo, Tsang, Kwong Y., Vandeveer, Amanda J., Gulley, James L., Schlom, Jeffrey

مصطلحات موضوعية: Male, Lymphoma, Non-Hodgkin, Receptors, IgG, Antibody-Dependent Cell Cytotoxicity, Antibodies, Monoclonal, Apoptosis, Middle Aged, Antibodies, Monoclonal, Humanized, GPI-Linked Proteins, Article, B7-H1 Antigen, Killer Cells, Natural, Immunoglobulin G, Tumor Cells, Cultured, Humans, Interleukin-2, Cell Proliferation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::3bae6e29d0f5c7dda85942d50817d2b6
https://europepmc.org/articles/PMC5604238/